Success Metrics

Clinical Success Rate
74.5%

Based on 35 completed trials

Completion Rate
74%(35/47)
Active Trials
36(33%)
Results Posted
46%(16 trials)
Terminated
12(11%)

Phase Distribution

Ph phase_3
3
3%
Ph phase_2
45
42%
Ph early_phase_1
3
3%
Ph phase_4
2
2%
Ph not_applicable
15
14%
Ph phase_1
18
17%

Phase Distribution

21

Early Stage

45

Mid Stage

5

Late Stage

Phase Distribution86 total trials
Early Phase 1First-in-human
3(3.5%)
Phase 1Safety & dosage
18(20.9%)
Phase 2Efficacy & side effects
45(52.3%)
Phase 3Large-scale testing
3(3.5%)
Phase 4Post-market surveillance
2(2.3%)
N/ANon-phased studies
15(17.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

35 of 49 finished

Non-Completion Rate

28.6%

14 ended early

Currently Active

36

trials recruiting

Total Trials

108

all time

Status Distribution
Active(45)
Completed(35)
Terminated(14)
Other(14)

Detailed Status

Completed35
Recruiting29
unknown14
Terminated12
Not yet recruiting8
Active, not recruiting7

Development Timeline

Analytics

Development Status

Total Trials
108
Active
36
Success Rate
74.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (3.5%)
Phase 118 (20.9%)
Phase 245 (52.3%)
Phase 33 (3.5%)
Phase 42 (2.3%)
N/A15 (17.4%)

Trials by Status

enrolling_by_invitation11%
not_yet_recruiting87%
active_not_recruiting76%
terminated1211%
unknown1413%
withdrawn22%
completed3532%
recruiting2927%

Recent Activity

Clinical Trials (108)

Showing 20 of 108 trialsScroll for more
NCT06487481Phase 1

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Recruiting
NCT07410715

Surgery vs. Watch-and-Wait Strategy in Partial & Complete Responders for Hepatocellular Carcinoma

Recruiting
NCT06492954Phase 1

Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

Recruiting
NCT02598349Phase 2

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Recruiting
NCT01857934Phase 2

Therapy for Children With Advanced Stage Neuroblastoma

Completed
NCT07829744Phase 2

Perioperative Targeted Therapy in Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer With Rare Driver Mutations

Not Yet Recruiting
NCT04977375Phase 1

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

Recruiting
NCT07826949Phase 1

A Phase 1 Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.

Not Yet Recruiting
NCT05535166Phase 2

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Recruiting
NCT07815054

Efficacy Evaluation of Microwave Ablation Assisted by Diaphragm Hydrodissection for Hepatocellular Carcinoma and Comparative Analysis With Surgical

Not Yet Recruiting
NCT05546827Phase 2

Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma

Recruiting
NCT07802353Not Applicable

A Study of Stereotactic Radiosurgery (SRS) in People With Brain Cancer Having Tumor Resection Surgery

Recruiting
NCT07062055Phase 2

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Recruiting
NCT02114229Phase 2

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

Active Not Recruiting
NCT07765667Phase 2

NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC

Not Yet Recruiting
NCT06186401Phase 1

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

Recruiting
NCT07748481

Comparison of the Therapeutic Efficacy of Non-touch Microwave Ablation, Tumor-puncture Microwave Ablation and Surgical Resection for Subcapsular Hepatocellular Carcinoma

Not Yet Recruiting
NCT06908031Phase 2

SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer

Completed
NCT06239272Phase 1

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Recruiting
NCT07741344Phase 2

Study of Robotic Assisted/Image Guided Electromagnetic Navigation Bronchoscopic Therapies and Surgery in Stage IA NSCLC

Not Yet Recruiting

Drug Details

Intervention Type
PROCEDURE
Total Trials
108